research institutions using ITG generators

ITM Isotope Technologies Munich SE is a leading radiopharmaceutical company that develops, produces, and distributes high-quality diagnostic and therapeutic radionuclides and radiopharmaceuticals. The company is widely recognized for its production of high-purity non-carrier-added Lutetium-177 (n.c.a. 177Lu) and its Germanium-68/Gallium-68 generators, which are essential for PET imaging in oncology. ITM is also advancing a robust proprietary pipeline of targeted radiotherapies, with its lead candidate, ITM-11, currently in Phase 3 clinical trials for the treatment of neuroendocrine tumors. By integrating its global supply network with innovative drug development, ITM provides precision oncology solutions to hospitals and research institutions worldwide. The company operates state-of-the-art manufacturing facilities that adhere to strict GMP standards for the production of medical isotopes.